Prevalence of Sexual Side Effects in Female Psychiatric Patients Taking Psychotropic Medications: A Cross-Sectional Study

ABSTRACT

Background: Many women experience sexual disorders or side effects due to factors such as age or medication use. The most common issues are lack of desire and inability to become aroused during sex. Women are more likely than men to suffer from sexual inefficiency, with a prevalence of 43% compared to 31% for men. This study aims to determine the prevalence and compare the types of sexual side effects of psychotropic medications in female psychiatric patients, while exploring the impact of socio-demographic factors and potential correlation with menstruation. Materials and Methods: An observational, prospective cross-sectional study was conducted on patients at the psychological medicine department of Dhiraj Hospital, SVDU. Patients with a history of psychiatric illness or those taking psychedelic medication for at least a month were included based on study criteria. The Female Sexual Function Index Scale was used, consisting of 19 questions divided into six domains representing sexual side effects in female patients: Desire, Arousal, Lubrication, Orgasm, Satisfaction, and Pain. Patient responses were collected and interpreted using the FSFI score to determine the final score. Results: According to the study, the prevalence of sexual problems varies among patients. Out of the population studied, 103 patients experienced desire problems, which accounts for 51.73% of the group. Arousal problems affected 110 patients, representing 55.23% of the population. Lubrication issues were reported by 138 patients, which represent a prevalence of 69.19%. The prevalence of orgasm problems was 62.25%, affecting 124 patients. A total of 164 patients suffered from satisfaction problems, resulting in a prevalence rate of 82.33%. In contrast, 120 patients reported pain, equating to a prevalence of 60.28%. Finally, the study found that 128 patients had a full score, which accounts for a prevalence rate of 64.26%. Conclusion: In summary, it is crucial to understand the sexual side effects that may arise due to psychotropic medication in women. This study highlights the prevalence of such side effects and the importance of addressing them to prevent additional stress on patients' mental health. Recognizing and discussing these potential side effects with healthcare providers can lead to better management of psychiatric conditions and improve the overall well-being of patients.

KEYWORDS

• Female Sexual Function Index Desire
• Arousal
• Lubrication
• Orgasm
• Satisfaction
• Pain

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2024.16.99Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 16, ISSUE 4Appropriateness Analysis of Proton Pump Inhibitor Use among General Medicine Inpatients of a Secondary Care Hospital: A Hospital Based Cross-Sectional StudyAswathy Melel Somarajan, Balaiahgari Mani Raja Rao, Donthula Pushpa, Anke Sai Kumar, Goruntla Narayana, Venkata Ramana, Akkiraju Sudheer · pp. 781–786Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4Factors Associated with Glycemic Control among Type 2 Diabetes Patients on Ayurveda TherapyRadhika Bindu, Shashwat Nagar, Abhay Dharamsi · pp. 795–798Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4Analyzing Lessons from Previous COVID-19 Outbreaks for Future Preparedness: A Cross-Sectional StudyMandati Santhosh Reddy, Akul Madiwalayya Ganachari, Ramesh Bhandari, Bandaru Yeshwanth Raja, Kurubara Amaresh · pp. 799–806Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4Determining the Predictors of Vaccine Hesitancy: A Nation-Wide Study Using WHO SAGE WG Developed Vaccine Hesitancy QuestionnaireSheba Baby John, Savitha Rajapur Sanathan, Juny Sebastian, Mandyam Dhati Ravi · pp. 807–811Original ArticleSame type: Article